Mr David Tamblyn
|Org Unit||Adelaide Health Technology Assessment|
|Telephone||+61 8 8313 0608|
Adelaide Health and Medical Sciences
Mr Tamblyn critically appraises the evidence provided in submissions of devices or drugs to the TGA for regulatory purposes and generates evidence based reports using systematic reviews for large contracted reviews of devices, drugs or to inform guidance or policy. Mr Tamblyn supports and manages staff performing such assessments and provides quality assurance of deliverables.
Regulatory assessments of Devices
Evaluation of the safety and performance of devices (including application audits and conformity assessments) for the Therapeutic Goods Administration. Evaluations involve the synthesis of pre-clinical data, clinical data, published studies, registry and post market surveillance data, risk management plans and activities, and the audit of product information or similar documents provided to health care practitioners and patients. Common indications for devices assessed are: orthopaedics, ophthalmology, cardiology, interventional radiology, pain management.
Regulatory assessments of Oncology Drugs
Evaluation of the safety, efficacy and pharmacology of new oncology drugs for the Therapeutic Goods Administration for regulatory purposes. Evaluations involve the assessment of the quality of the clinical evidence (Module 5) of a pharmaceutical, which is synthesised into a benefit / risk profile, and a recommendation to the ACM and/or TGA delegate.
Evaluation of pharmaceutical submissions to the PBAC for reimbursement on the PBS.
Contract based evaluations of medical services for consideration by MSAC for inclusion on the MBS.
Projects involving systematic reviews
- Review of a class of devices for the TGA
- Review of the Life Saving Drugs Programme
- Review of the Statins Therapeutic Group
- Vertebroplasy / Kyphoplasty for the treatment of vertebral compression fracture
- Brachytherapy for the treatment of prostate cancer
- National Evidence Based Guidelines for the Prevention, Identification and Management of Foot Complications in Diabetes
- Co-lead researcher for "Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee, Version 5.0"
- Review of MBS Items for specific ophthalmology services under the MBS Quality Framework
Master of Public Health, University of Adelaide (2011)
Bachelor of Health Science, University of Adelaide (2001)
University Teaching for Effective Student Learning, University of Adelaide, 2014
MAEFA courses: Quantitative Analysis using Stata 13, Working Efficiently with Stata 13, Programming with Stata 13, Raw Data Management with Stata 13
TreeAge Pro Training: Cost-effectiveness models, Markov models and Micro-simulation
Survival Analysis short course (Monash)
Modelling Methods for Health Economic Evaluations (University of York, McMaster University collaboration)
Introduction to Network Meta-analysis / Mixed treatment comparisons (CADTH)
Peer reviewed publications
Leach, Damien A., Eleanor F. Need, Roxanne Toivanen, Andrew P. Trotta, Helen M. Palenthorpe, David J. Tamblyn, Tina Kopsaftis et al. "Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome." Oncotarget (2015).
Merlin, Tracy, David Tamblyn, and Benjamin Ellery. "What's in a name? Developing definitions for common health technology assessment product types of the international network of agencies for health technology assessment (INAHTA)." International journal of technology assessment in health care (2014): 1-8.
Tamblyn, DJ, Chopra, S, Yu, C, Kattan, MW, Pinnock, C & Kopsaftis, T 2011, 'Comparative analysis of three risk assessment tools in Australian patients with prostate cancer', BJU International, vol. 108, pp. 51-56.
Beckmann, K, Pinnock, CB, Tamblyn, DJ, Kopsaftis, T, Stapleton, AMF & Roder, DM 2009, 'Clinical and socio-demographic profile of an Australian multi-institutional prostate cancer cohort', Asia-Pacific Journal of Clinical Oncology, vol. 5, no. 4, pp. 247-256.
Stapleton, AM, Johns, RL, Kopsaftis, T, Tamblyn, DJ & Pinnock, CB 2008, 'Abnormal PSA tests--delays in referral', Aust Fam Physician, vol. 37, no. 1-2, Jan-Feb, pp. 84-88.
Selected contracted reports
Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee, Version 5.0. September 2016. Commonwealth of Australia, Canberra, ACT.
Tamblyn, DJ, Ellery, B & Merlin, T 2011, Brachytherapy for the treatment of prostate cancer. MSAC Application 1089.1, Review of Interim Funded Service, Commonwealth of Australia, Canberra, ACT.
Doidge, J, Merlin, T, Liufu, Z, Tamblyn, DJ, Jia, LY & Hiller, JE 2011, Review of interim funded service: Vertebroplasty and new review of Kyphoplasty. MSAC Application 27.1, Commonwealth of Australia, Canberra, ACT.
Morona, JK, Newton, S, Wang, S, Tamblyn, DJ, Ellery, B & Merlin, T 2014, Genetic testing for hereditary mutations in the VHL gene that cause von Hippel-Lindau syndrome. MSAC Application 1153, Assessment Report., Commonwealth of Australia, Canberra, ACT.
Merlin, T, Street, J, Holton, C, Mundy, L, Tamblyn, DJ, Ellery, B, Juneja, V, Reddin, E, Scrimgeour, S & Hennessy, S 2011, Review of MBS Items for specific ophthalmology services under the MBS Quality Framework., Commonwealth of Australia, Canberra, ACT.
Deputy Editor, International Journal of Technology Assessment in Health Care https://www.cambridge.org/core/journals/international-journal-of-technology-assessment-in-health-care
Committee Member, South Australian Policy Advisory Committee on Technology (SAPACT)
Working Group Member, TGA Expert Working Group for Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Agency Member, International Network of Agencies for Health Technology Assessment (INAHTA)
Individual Member, Health Technology Assessment International (HTAi)
The information in this directory is provided to support the academic, administrative and business activities of the University of Adelaide. To facilitate these activities, entries in the University Phone Directory are not limited to University employees. The use of information provided here for any other purpose, including the sending of unsolicited commercial material via email or any other electronic format, is strictly prohibited. The University reserves the right to recover all costs incurred in the event of breach of this policy.
Entry last updated: Thursday, 12 Mar 2020
To link to this page, please use the following URL: https://www.adelaide.edu.au/directory/david.tamblyn